CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Evaluation of anti-ccp for early diagnosis and assessment of disease severity in rheumatoid arthritis patients

Author: 
Mohammad Nezam Uddin, Sujat Paul, Sattar, M.A., Golam Faruk, Anwarul Kibria, Mohiuddin Mohammad Alamgir, Rajat Sanker Roy Biswas, Mohammed Rezaul Karim, Kamrul Hasan Lohani, Ratan Kumar Nath and Mizanur Rahman
Subject Area: 
Health Sciences
Abstract: 

Rheumatoid Arthritis is a severe, progressive, systemic inflammatory disease of unknown etiology characterized by chronic and erosive polyarthritis by abnormal growth of synovial tissue or pannus and causes irreversible joint disability. The diagnosis of RA, particularly early in the course of disease is empirical and imprecise. A study was carried out on 100 patients who were presented with polyarthritis within one year of presentation. The patients were divided into two groups. 50 patients who fulfilled the ARA criteria for RA were included in Group A. Again 50 patients who had polyarthritis but not fulfilled the ARA criteria were included in Group B. The patients were evaluated clinically and investigated. The anti CCP antibody was analyzed in relation with its sensitivity and specificity and also with different activity markers of RA. It was found that the specificity and sensitivity of Anti CCP was 86% and 64% respectively in early presentation of RA. The activity marker of RA were significantly correlated (DAS 28 score r=0.912; CRP, r=0.323; and VAS, r=0.382) with the increasing titre of Anti CCP (p<0.01). ESR were not correlated with the increasing titre of anti-CCP levels (r=0.016, p>0.05). Anti – CCP has high specificity and moderate sensitivity in the early presentation of RA. So it can be used as a reliable serological marker for early diagnosis of RA. The increasing titre also significantly correlated with increasing disease activity markers. So anti-CCP can be used as a reliable serological marker for early diagnosis and assessment of disease severity.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran